We are proud to announce that Defytime Holdings, a new company that is focused on discovering a radical cure to Telomerase Enzyme Deficiency Syndrome (TEDS), has chosen Fanfare […]
We are delighted to announce that LDJ Capital has inked a strategic partnership alliance with us for fund-raising, project development and business expansion. LDJ Capital is a multi-family […]
